Slot System
Featured Buckets
Featured Buckets Admin

The newer antimuscarinic drugs: Bladder control with less dry mouth

Article Type
Changed
Fri, 12/14/2018 - 09:18
Display Headline
The newer antimuscarinic drugs: Bladder control with less dry mouth
Article PDF
Author and Disclosure Information

Rodney A. Appell, MD
F. Brantley Scott Professor of Voiding Dysfunction, Department of Urology, Baylor College of Medicine, Houston

Address: Rodney A. Appell, MD, Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030; e-mail rappell@bcm.tmc.edu

Dr. Appell has received grant and research support from Alza Corporation, is a consultant for the Alza and Pharmacia corporations, and is on the speakers’ bureau of Pharmacia.

Issue
Cleveland Clinic Journal of Medicine - 69(10)
Publications
Topics
Page Number
761, 765-766, 768-769
Sections
Author and Disclosure Information

Rodney A. Appell, MD
F. Brantley Scott Professor of Voiding Dysfunction, Department of Urology, Baylor College of Medicine, Houston

Address: Rodney A. Appell, MD, Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030; e-mail rappell@bcm.tmc.edu

Dr. Appell has received grant and research support from Alza Corporation, is a consultant for the Alza and Pharmacia corporations, and is on the speakers’ bureau of Pharmacia.

Author and Disclosure Information

Rodney A. Appell, MD
F. Brantley Scott Professor of Voiding Dysfunction, Department of Urology, Baylor College of Medicine, Houston

Address: Rodney A. Appell, MD, Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030; e-mail rappell@bcm.tmc.edu

Dr. Appell has received grant and research support from Alza Corporation, is a consultant for the Alza and Pharmacia corporations, and is on the speakers’ bureau of Pharmacia.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(10)
Issue
Cleveland Clinic Journal of Medicine - 69(10)
Page Number
761, 765-766, 768-769
Page Number
761, 765-766, 768-769
Publications
Publications
Topics
Article Type
Display Headline
The newer antimuscarinic drugs: Bladder control with less dry mouth
Display Headline
The newer antimuscarinic drugs: Bladder control with less dry mouth
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Inflammatory bowel disease: Sorting out the treatment options

Article Type
Changed
Thu, 12/13/2018 - 15:16
Display Headline
Inflammatory bowel disease: Sorting out the treatment options
Article PDF
Author and Disclosure Information

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail lashneb@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 69(8)
Publications
Topics
Page Number
621-626, 629-631
Sections
Author and Disclosure Information

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail lashneb@ccf.org

Author and Disclosure Information

Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic

Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic

Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail lashneb@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(8)
Issue
Cleveland Clinic Journal of Medicine - 69(8)
Page Number
621-626, 629-631
Page Number
621-626, 629-631
Publications
Publications
Topics
Article Type
Display Headline
Inflammatory bowel disease: Sorting out the treatment options
Display Headline
Inflammatory bowel disease: Sorting out the treatment options
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Aromatase inhibitors in breast cancer: Current and evolving roles

Article Type
Changed
Thu, 12/13/2018 - 11:54
Display Headline
Aromatase inhibitors in breast cancer: Current and evolving roles
Article PDF
Author and Disclosure Information

John Hill, MD
Department of Hematology and Medical Oncology, The ClevelandClinic

Halle Moore, MD
Associate Professor, Department of Hematology and Clinical Oncology, The Cleveland Clinic

Address: Halle Moore, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mooreh1@ccf.org

This paper discusses treatments that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 69(7)
Publications
Topics
Page Number
561-567
Sections
Author and Disclosure Information

John Hill, MD
Department of Hematology and Medical Oncology, The ClevelandClinic

Halle Moore, MD
Associate Professor, Department of Hematology and Clinical Oncology, The Cleveland Clinic

Address: Halle Moore, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mooreh1@ccf.org

This paper discusses treatments that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

John Hill, MD
Department of Hematology and Medical Oncology, The ClevelandClinic

Halle Moore, MD
Associate Professor, Department of Hematology and Clinical Oncology, The Cleveland Clinic

Address: Halle Moore, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mooreh1@ccf.org

This paper discusses treatments that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(7)
Issue
Cleveland Clinic Journal of Medicine - 69(7)
Page Number
561-567
Page Number
561-567
Publications
Publications
Topics
Article Type
Display Headline
Aromatase inhibitors in breast cancer: Current and evolving roles
Display Headline
Aromatase inhibitors in breast cancer: Current and evolving roles
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

How to prevent, recognize, and treat drug-induced nephrotoxicity

Article Type
Changed
Mon, 12/17/2018 - 14:22
Display Headline
How to prevent, recognize, and treat drug-induced nephrotoxicity
Article PDF
Author and Disclosure Information

Xiaoqing Guo, MD
Internal Medicine Program, Morehouse School of Medicine, Atlanta, GA

Chike Nzerue, MD
Renal Division, Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA

Address: Chike Nzerue, MD, Renal Division, Department of Internal Medicine, Morehouse School of Medicine, 720 Westview Drive, SW, Atlanta, GA 30310; e-mail: cmnzerue@aol.com

Issue
Cleveland Clinic Journal of Medicine - 69(4)
Publications
Topics
Page Number
289-290, 293-294, 296-297, 303-305, 309-312
Sections
Author and Disclosure Information

Xiaoqing Guo, MD
Internal Medicine Program, Morehouse School of Medicine, Atlanta, GA

Chike Nzerue, MD
Renal Division, Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA

Address: Chike Nzerue, MD, Renal Division, Department of Internal Medicine, Morehouse School of Medicine, 720 Westview Drive, SW, Atlanta, GA 30310; e-mail: cmnzerue@aol.com

Author and Disclosure Information

Xiaoqing Guo, MD
Internal Medicine Program, Morehouse School of Medicine, Atlanta, GA

Chike Nzerue, MD
Renal Division, Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA

Address: Chike Nzerue, MD, Renal Division, Department of Internal Medicine, Morehouse School of Medicine, 720 Westview Drive, SW, Atlanta, GA 30310; e-mail: cmnzerue@aol.com

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(4)
Issue
Cleveland Clinic Journal of Medicine - 69(4)
Page Number
289-290, 293-294, 296-297, 303-305, 309-312
Page Number
289-290, 293-294, 296-297, 303-305, 309-312
Publications
Publications
Topics
Article Type
Display Headline
How to prevent, recognize, and treat drug-induced nephrotoxicity
Display Headline
How to prevent, recognize, and treat drug-induced nephrotoxicity
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Statins and osteoporosis: Can these lipid-lowering drugs also bolster bones?

Article Type
Changed
Mon, 12/17/2018 - 14:17
Display Headline
Statins and osteoporosis: Can these lipid-lowering drugs also bolster bones?
Article PDF
Author and Disclosure Information

Abelardo C. Cruz, MD
Division of Rheumatology, Department of Medicine, State University of New York at Stony Brook

Barry L. Gruber, MD
Head, Division of Rheumatology, Professor of Medicine and Dermatology, State University of New York at Stony Brook

Address: Abelardo C. Cruz, MD, State University of New York at Stony Brook, Division of Rheumatology, HSC T-16, Room 040, Stony Brook, NY 11794-8161; e-mail: geriatricrheum@yahoo.com

Issue
Cleveland Clinic Journal of Medicine - 69(4)
Publications
Topics
Page Number
277-278, 280-282, 287-288
Sections
Author and Disclosure Information

Abelardo C. Cruz, MD
Division of Rheumatology, Department of Medicine, State University of New York at Stony Brook

Barry L. Gruber, MD
Head, Division of Rheumatology, Professor of Medicine and Dermatology, State University of New York at Stony Brook

Address: Abelardo C. Cruz, MD, State University of New York at Stony Brook, Division of Rheumatology, HSC T-16, Room 040, Stony Brook, NY 11794-8161; e-mail: geriatricrheum@yahoo.com

Author and Disclosure Information

Abelardo C. Cruz, MD
Division of Rheumatology, Department of Medicine, State University of New York at Stony Brook

Barry L. Gruber, MD
Head, Division of Rheumatology, Professor of Medicine and Dermatology, State University of New York at Stony Brook

Address: Abelardo C. Cruz, MD, State University of New York at Stony Brook, Division of Rheumatology, HSC T-16, Room 040, Stony Brook, NY 11794-8161; e-mail: geriatricrheum@yahoo.com

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 69(4)
Issue
Cleveland Clinic Journal of Medicine - 69(4)
Page Number
277-278, 280-282, 287-288
Page Number
277-278, 280-282, 287-288
Publications
Publications
Topics
Article Type
Display Headline
Statins and osteoporosis: Can these lipid-lowering drugs also bolster bones?
Display Headline
Statins and osteoporosis: Can these lipid-lowering drugs also bolster bones?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Dofetilide (Tikosyn): A new drug to control atrial fibrillation

Article Type
Changed
Mon, 03/04/2019 - 08:26
Display Headline
Dofetilide (Tikosyn): A new drug to control atrial fibrillation
Article PDF
Author and Disclosure Information

Walid I. Saliba, MD
Section of Cardiac Electrophysiology and Pacing, Department of Cardiology, Cleveland Clinic

Address: Walid I. Saliba, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; salibaw@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 68(4)
Publications
Topics
Page Number
353-363
Sections
Author and Disclosure Information

Walid I. Saliba, MD
Section of Cardiac Electrophysiology and Pacing, Department of Cardiology, Cleveland Clinic

Address: Walid I. Saliba, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; salibaw@ccf.org

Author and Disclosure Information

Walid I. Saliba, MD
Section of Cardiac Electrophysiology and Pacing, Department of Cardiology, Cleveland Clinic

Address: Walid I. Saliba, MD, Department of Cardiology, F15, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; salibaw@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Issue
Cleveland Clinic Journal of Medicine - 68(4)
Page Number
353-363
Page Number
353-363
Publications
Publications
Topics
Article Type
Display Headline
Dofetilide (Tikosyn): A new drug to control atrial fibrillation
Display Headline
Dofetilide (Tikosyn): A new drug to control atrial fibrillation
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Phenylpropanolamine and stroke: The study, the FDA ruling, the implications

Article Type
Changed
Fri, 03/01/2019 - 08:18
Display Headline
Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
Article PDF
Author and Disclosure Information

Tracey L. Mersfelder, PharmD
College of Pharmacy, Ferris State University, Grand Rapids, Michigan

Address: Tracey L. Mersfelder, PharmD, 715 Xavier Hall, 220 Cherry Street SE, Grand Rapids, Ml 49503

Issue
Cleveland Clinic Journal of Medicine - 68(3)
Publications
Topics
Page Number
208-209, 213-219, 223
Sections
Author and Disclosure Information

Tracey L. Mersfelder, PharmD
College of Pharmacy, Ferris State University, Grand Rapids, Michigan

Address: Tracey L. Mersfelder, PharmD, 715 Xavier Hall, 220 Cherry Street SE, Grand Rapids, Ml 49503

Author and Disclosure Information

Tracey L. Mersfelder, PharmD
College of Pharmacy, Ferris State University, Grand Rapids, Michigan

Address: Tracey L. Mersfelder, PharmD, 715 Xavier Hall, 220 Cherry Street SE, Grand Rapids, Ml 49503

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Issue
Cleveland Clinic Journal of Medicine - 68(3)
Page Number
208-209, 213-219, 223
Page Number
208-209, 213-219, 223
Publications
Publications
Topics
Article Type
Display Headline
Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
Display Headline
Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Cisapride: Limited access and alternatives

Article Type
Changed
Tue, 02/12/2019 - 11:45
Display Headline
Cisapride: Limited access and alternatives
Article PDF
Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195; richtej@ccf.org

Dr. Richter discusses off-label use of medications.

Issue
Cleveland Clinic Journal of Medicine - 67(7)
Publications
Topics
Page Number
471-472
Sections
Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195; richtej@ccf.org

Dr. Richter discusses off-label use of medications.

Author and Disclosure Information

Joel E. Richter, MD
Chairman, Department of Gastroenterology, Cleveland Clinic

Address: Joel E. Richter, MD, Department of Gastroenterology, S40, Cleveland Clinic, 9500
Euclid Avenue, Cleveland, OH 44195; richtej@ccf.org

Dr. Richter discusses off-label use of medications.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Issue
Cleveland Clinic Journal of Medicine - 67(7)
Page Number
471-472
Page Number
471-472
Publications
Publications
Topics
Article Type
Display Headline
Cisapride: Limited access and alternatives
Display Headline
Cisapride: Limited access and alternatives
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Appropriate use of second-generation antihistamines

Article Type
Changed
Mon, 02/11/2019 - 09:37
Display Headline
Appropriate use of second-generation antihistamines
Article PDF
Author and Disclosure Information

Lily C. Pien, MD
Department of Allergy and Immunology, Cleveland Clinic

Address: Lily C. Pien, MD, Department of Allergy and Immunology, A72, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; pienl@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 67(5)
Publications
Topics
Page Number
372-380
Sections
Author and Disclosure Information

Lily C. Pien, MD
Department of Allergy and Immunology, Cleveland Clinic

Address: Lily C. Pien, MD, Department of Allergy and Immunology, A72, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; pienl@ccf.org

Author and Disclosure Information

Lily C. Pien, MD
Department of Allergy and Immunology, Cleveland Clinic

Address: Lily C. Pien, MD, Department of Allergy and Immunology, A72, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; pienl@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(5)
Issue
Cleveland Clinic Journal of Medicine - 67(5)
Page Number
372-380
Page Number
372-380
Publications
Publications
Topics
Article Type
Display Headline
Appropriate use of second-generation antihistamines
Display Headline
Appropriate use of second-generation antihistamines
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Using viral load, CD4+ levels, and clinical response to guide antiviral therapy for HIV

Article Type
Changed
Wed, 02/13/2019 - 08:58
Display Headline
Using viral load, CD4+ levels, and clinical response to guide antiviral therapy for HIV
Article PDF
Author and Disclosure Information

Leonard H. Calabrese, DO
R.J. Fasenmyer Chair of Clinical Immunology, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Leonard H. Calabres,e DO, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195; calabrl@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 67(5)
Publications
Topics
Page Number
321, 325-326, 328
Sections
Author and Disclosure Information

Leonard H. Calabrese, DO
R.J. Fasenmyer Chair of Clinical Immunology, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Leonard H. Calabres,e DO, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195; calabrl@ccf.org

Author and Disclosure Information

Leonard H. Calabrese, DO
R.J. Fasenmyer Chair of Clinical Immunology, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Leonard H. Calabres,e DO, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195; calabrl@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 67(5)
Issue
Cleveland Clinic Journal of Medicine - 67(5)
Page Number
321, 325-326, 328
Page Number
321, 325-326, 328
Publications
Publications
Topics
Article Type
Display Headline
Using viral load, CD4+ levels, and clinical response to guide antiviral therapy for HIV
Display Headline
Using viral load, CD4+ levels, and clinical response to guide antiviral therapy for HIV
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media